Fabien is an expert in bioprocess industrialization with a strong focus on the field of cell and gene therapy. After a decade of experience in the CDO (contract development organisation) business unit of Artelis, ATMI and PALL where he lead application specialists and process development departments across EU and US, Fabien started in 2016 to collaborate, as a freelance, with start-up and SME. In this new role, he offers to contributes in the elaboration of adequate process design and manufacturing strategies to be in accordance with the specific clinical development and corporate constraints. Through his experience, Fabien led a wide variety of projects in Europe and in the US to optimize and scale-up manufacturing processes of stem cells, viral vectors and vaccines.
With his teams, he has overseen production processes of multiple stem and adult cell types (MSC, iPSC, Hepatocytes, Hematpoietic stem cells) as well as viral vectors (AAV, Adenoviruses and Lentiviruses). Fabien is currently in charge of the industrialization strategy of Goliver Therapeutics and part of their Strategic committee. He is a member of TreeFrog Therapeutics’ executive team and is also collaborating with Flash Therapeutics on their Lentivirus GMP production process.